Target intelligence / Profile preview

Ribosomal protein SA pseudogene 64 (RPSAP64)

Target
RPSAP64
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein SA pseudogene 64 (RPSAP64) is annotated as a pseudogene of the Ribosomal protein SA (RPSA) gene. Pseudogenes are genomic sequences similar to known genes but lack coding potential due to mutations or truncations. RPSAP64 does not encode a protein and is not involved in cellular processes or pathologies as an active molecule. There is no scientific evidence that RPSAP64 is a molecular target for drugs, nor does it have disease associations, biological functions, or biomarker status. Its presence reflects the evolutionary expansion of the RPSA gene family, which includes numerous processed pseudogenes across mammalian genomes. RPSAP64 is listed in gene databases (NCBI, Ensembl, GeneCards) as a pseudogene and not as a protein-coding gene or a functional therapeutic target. Functionally, only the parent gene RPSA encodes the active 40S ribosomal protein SA, which has roles as a ribosomal protein and laminin receptor, but RPSAP64 does not contribute to these functions. No associations are documented for RPSAP64 with diseases, drug interactions, biological pathways, or therapeutics. This nomenclature is correct for a pseudogene but would be incorrect if interpreted as an actionable therapeutic target.

Other names
RPSAP64

Beyond the preview

Go deeper on Ribosomal protein SA pseudogene 64 (RPSAP64).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein SA pseudogene 64 (RPSAP64).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call